Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Caterpillar fungus believed to cure ailments
Scientists discover fungus has anti-inflammatory properties

A new study, published in the journal RNA, has shed light on the “golden worm” or “Tibetan mushroom” thought by locals in Tibet to cure everything from cancer to asthma to erectile dysfunction.

For a Tibetan mushroom to form, a fungus must attach itself to a moth larva burrowed in the soil. It will then slowly consume the host from within, taking over its brain and making the young caterpillar move to position which the fungus can grow and spore again.

The parasite is called cordyceps and produces the chemical cordycepin which scientists now believe has anti-inflammatory properties.

Study co-author Cornelia H. de Moor, of the University of Nottingham, explained: "Inflammation is normally a beneficial response to a wound or infection, but in diseases like asthma it happens too fast and to too high of an extent. When cordycepin is present, it inhibits that response strongly."

The chemical does this in a way not previously seen: at the mRNA stage, where it inhibits polyadenylation. This means it stops swelling at the genetic cellular level - a novel anti-inflammatory approach that could lead to new drugs for cancer, asthma, diabetes, rheumatoid arthritis, and cardiovascular-disease patients who don't respond well to current medications.

However, these new drugs may be a long way off. The science of parasitic fungi is still in its early stages, and no medicine currently available utilises cordycepin as an anti-inflammatory. The only way a patient could gain its benefits would be by consuming wild-harvested mushrooms.

"I can't recommend taking wild-harvested medications," warned de Moor. "Each sample could have a completely different dose, and there are mushrooms where a single bite will kill you."

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.